Core Viewpoint - The article highlights the production of sodium-ion batteries in China, indicating a growing trend in the industry with significant contributions from leading companies [1]. Group 1: Industry Overview - In the first half of 2025, the domestic production of sodium-ion batteries reached 2.1 GWh [1]. - The top five companies in the sodium-ion battery sector are CATL, Zhongke Haona, BYD, Haifida, and Weike Technology [1].

[Veken Technology Co., Ltd. H1 2025 Preliminary Loss Announcement](index=1&type=section&id=%E7%BB%B4%E7%A7%91%E6%8A%80%E6%9C%AF%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%202025%20%E5%B9%B4%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%9A%E7%BB%A9%E9%A2%84%E4%BA%8F%E5%85%AC%E5%91%8A) [Performance Forecast for the Current Period](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) The company forecasts a net loss attributable to parent company shareholders of approximately CNY -37.10 million for H1 2025 H1 2025 Performance Forecast | Metric | Estimated Amount (CNY '0000) | | :--- | :--- | | Net profit attributable to owners of the parent company | Approx -3,710.00 | | Net profit attributable to owners of the parent company after deducting non-recurring gains and losses | Approx -4,970.00 | - Compared to the same period last year, the company's **projected loss for H1 2025 is expected to increase**[4](index=4&type=chunk) - The financial data in this performance forecast has **not been audited** by a certified public accountant[4](index=4&type=chunk) [Operating Performance and Financial Status for the Same Period Last Year](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8A%E5%B9%B4%E5%90%8C%E6%9C%9F%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%92%8C%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5) In H1 2024, the company reported a net loss of CNY -7.31 million and an EPS of CNY -0.0138 H1 2024 (Prior Year Period) Performance Data | Metric | Amount | | :--- | :--- | | Total Profit | -7.50 million CNY | | Net profit attributable to owners of the parent company | -7.31 million CNY | | Net profit attributable to owners of the parent company after deducting non-recurring gains and losses | -19.62 million CNY | | Earnings Per Share | -0.0138 CNY | [Main Reasons for the Estimated Loss in the Current Period](index=1&type=section&id=%E4%B8%89%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E4%BA%8F%E7%9A%84%E4%B8%BB%E8%A6%81%E5%8E%9F%E5%9B%A0) The projected loss is mainly due to a significant inventory write-down, which offset gains from a property disposal [Impact from Main Business Operations](index=1&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%BD%B1%E5%93%8D) A CNY 20.46 million inventory write-down was the primary negative factor impacting main business profit - During the reporting period, the company made a **provision for inventory write-down of CNY 20.46 million**[7](index=7&type=chunk) - During the reporting period, the company **reversed a credit impairment loss of CNY 3.13 million**[7](index=7&type=chunk) [Impact from Non-recurring Gains and Losses](index=2&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%E9%9D%9E%E7%BB%8F%E8%90%A5%E6%80%A7%E6%8D%9F%E7%9B%8A%E7%9A%84%E5%BD%B1%E5%93%8D) The company generated a disposal gain of CNY 10.08 million from the sale of a property in Shenzhen - The company's wholly-owned subsidiary generated a **disposal gain of CNY 10.08 million** from the public sale of a property in Shenzhen[7](index=7&type=chunk) [Risk Warning](index=2&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The preliminary financial data is unaudited and subject to change upon final review - This performance forecast is a preliminary result from the finance department and is **unaudited** by a certified public accountant[8](index=8&type=chunk) - The company states that there are no major uncertainties affecting the accuracy of this performance forecast[8](index=8&type=chunk) [Other Explanations](index=2&type=section&id=%E4%BA%94%E3%80%81%E5%85%B6%E4%BB%96%E8%AF%B4%E6%98%8E%E4%BA%8B%E9%A1%B9) Investors are advised to refer to the official H1 2025 report for final figures and to be aware of investment risks - The final accurate financial data will be disclosed in the company's official H1 2025 report, and investors are urged to be mindful of investment risks[9](index=9&type=chunk)

New Stock Offerings - Jichuan Pharmaceutical (600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - *ST Yazhen (603389) has a tender offer period from June 10, 2025, to July 9, 2025[1] - Zhongcheng Tui (300208) has 11 trading days remaining until the last trading day[1] Delisting and Trading Reminders - Tui Shi Jin Gang (600190) has 11 trading days remaining until the last trading day[1] - Hengli Tui (000622) is in the delisting arrangement period with 8 trading days remaining[1] - Tui Shi Jiu You (600462) has 7 trading days remaining until the last trading day[1] Market Volatility - Beifang Changlong (301357) reported severe abnormal fluctuations[1] - Multiple companies, including Jichuan Pharmaceutical and *ST Yazhen, are under scrutiny for trading anomalies[1]

Core Viewpoint - The announcement details the results of the company's 2022 stock option incentive plan for the second quarter of 2025, indicating that no stock options were exercised during this period [1][7]. Summary by Sections Incentive Plan Overview - The 2022 stock option incentive plan's decision-making process and related disclosures were approved by the board, with independent directors providing opinions and the supervisory board verifying the initial grant of stock options [1][2][3]. Exercise Results - For the second quarter of 2025, the total number of stock options that could be exercised was 0, with no shares transferred during the exercise window from April 1, 2025, to June 30, 2025 [1][8]. - The total number of eligible participants for the incentive plan was 194, but none exercised their options, resulting in a cumulative exercise of 3,906,228 shares, which represents 66.64% of the total options granted for the first exercise period [7][8]. Stock Listing and Trading Arrangements - The stock obtained through the exercise of options is subject to a listing and trading arrangement, where shares will be available for trading on the second trading day after the exercise date (T+2) [8][9]. Share Structure Changes - There were no changes in the share structure as a result of the exercise, with the total number of shares remaining at 529,079,375 [9]. Financial Impact - The exercise of stock options did not have a significant impact on the company's financial status or operating results [9].

Market Overview - The Shanghai Composite Index rose by 0.39% on July 1, with 20 out of 28 sectors experiencing gains. The top-performing sectors were Comprehensive and Pharmaceutical & Biological, with increases of 2.60% and 1.80% respectively. Conversely, the Computer and Retail sectors saw declines of 1.18% and 0.79% [1]. Electric Equipment Industry - The Electric Equipment sector declined by 0.37%, with a net outflow of 5.163 billion yuan in main capital. Out of 358 stocks in this sector, 141 rose, 3 hit the daily limit up, while 210 fell, with 1 hitting the daily limit down [1]. - Among the stocks with net inflows, 112 saw capital inflows, with 11 stocks receiving over 50 million yuan. The top stock for net inflow was C Xintong, with 399 million yuan, followed by Weilan Lithium and Micro Light, with inflows of 218 million yuan and 132 million yuan respectively [1]. - The stocks with the highest net outflows included Rongfa Nuclear Power, Weike Technology, and Nord Shares, with outflows of 347 million yuan, 324 million yuan, and 323 million yuan respectively [1][2]. Capital Flow Rankings Inflow Rankings - C Xintong: +286.36%, turnover rate 82.61%, main capital flow 398.73 million yuan - Weilan Lithium: +5.30%, turnover rate 10.44%, main capital flow 217.95 million yuan - Micro Light: +10.01%, turnover rate 7.41%, main capital flow 131.92 million yuan [1]. Outflow Rankings - Rongfa Nuclear Power: +1.71%, turnover rate 33.83%, main capital flow -346.51 million yuan - Weike Technology: +3.55%, turnover rate 37.48%, main capital flow -324.04 million yuan - Nord Shares: -10.01%, turnover rate 23.39%, main capital flow -323.30 million yuan [2].

New Stock Issuance - The new stock "同宇新材" (code: 301630) is listed at an issuance price of 84.00[1] - "信通电子" (code: 001388) has an issuance price of 16.42[1] Rights Issues and Announcements - "济川药业" (code: 600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - "中程退" (code: 300208) has 13 trading days remaining until the last trading day[1] - "退市锦港" (code: 600190) also has 13 trading days remaining until the last trading day[1] - "恒立退" (code: 000622) has 10 trading days remaining until the last trading day[1] Abnormal Fluctuations - "浙江东日" (code: 600113) reported severe abnormal fluctuations[1] - "汇金股份" (code: 300368) is noted for abnormal fluctuations[3]

证券代码：600152 证券简称：维科技术 公告编号：2025-030 维科技术股份有限公司 关于公司 2022 年股票期权激励计划 2025 年第二季度 自主行权结果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 4、2022 年 7 月 11 日，公司召开了第十届董事会第十八次会议和第十届监 事会第十四次会议，审议通过了《关于向 2022 年股票期权激励计划激励对象首 次授予股票期权的议案》。公司独立董事对此发表了独立意见，监事会对首次授 予激励对象名单及授予相关事项进行了核实，律师事务所出具了法律意见书。 5、2022 年 8 月 4 日，公司召开了第十届董事会第十九次会议和第十届监事 会第十五次会议，审议通过了《关于调整 2022 年股票期权激励计划首次授予激 励对象名单及期权数量的议案（调整后）》《关于向 2022 年股票期权激励计划激 励对象首次授予股票期权的议案（调整后）》。公司独立董事对此发表了独立意见， 监事会对首次授予激励对象名单（调整后）及授予相关事项进行了核实，律师事 务所出具了 ...

Core Viewpoint - The stock of Weike Technology (stock code: 600152) experienced abnormal trading fluctuations, with a cumulative closing price increase exceeding 20% over two consecutive trading days on June 27 and June 30, 2025 [1][3]. Group 1: Stock Trading Abnormalities - The stock price fluctuation is classified as abnormal according to the Shanghai Stock Exchange trading rules due to the significant price deviation [1][3]. - The company conducted an internal review and confirmed that its production and operational activities are normal, with no significant changes in market conditions or industry policies [1][2]. Group 2: Major Events and Shareholder Actions - There are no undisclosed major events affecting the stock price, including significant asset restructuring, share issuance, acquisitions, or other major corporate actions [1][2]. - The company disclosed a shareholder reduction plan on May 27, 2025, allowing for the reduction of up to 5,290,793 shares, representing 0.9999% of the total share capital, within a specified period [2]. - A notification regarding a change in shareholding by Ningbo Industrial Investment Co., Ltd. was also disclosed, with a reduction in shareholding from 6.74% to 6.67% [2]. Group 3: Market Sentiment and Information Disclosure - The company found no media reports or market rumors that could significantly impact the stock price [2][3]. - The board of directors confirmed that there are no undisclosed matters that should be reported according to the stock listing rules, ensuring transparency in information disclosure [4].

证券代码：600152 证券简称：维科技术 公告编号：2025-029 维科技术股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、股票交易异常波动的具体情况 公司股票（股票代码：600152，股票简称：维科技术）于 2025 年 6 月 27 日、6 月 30 日连续两个交易日收盘价格涨幅偏离值累计超过 20%，根据《上海 证券交易所交易规则》（以下简称"《股票上市规则》"）的有关规定，公司股票 交易属于异常波动的情形。 二、公司关注并核实的相关情况 针对股票异常波动情况，公司对有关事项进行了核查，现将有关情况说明 如下： （一）生产经营情况 经公司自查，公司目前生产经营活动正常，市场环境、行业政策未发生重 大调整，生产成本和销售未出现大幅波动，公司内部生产经营秩序正常。 （二）重大事项情况 经向公司控股股东维科控股集团股份有限公司（以下简称"维科控股"）及 实际控制人何承命先生发问询函核实。截至本公告日，公司、维科控股、实际 控制人不存在影响公司股票交易异常波动的重大事项 ...

Group 1 - The core point of the article is that Ningbo Industrial Investment Co., Ltd. reduced its shareholding in Weike Technology by 351,000 shares, representing 0.0663% of the company's total equity during the period from June 19 to June 24, 2025 [1] - Following this reduction, Ningbo Industrial Investment's ownership in Weike Technology decreased from 6.74% to 6.67% [1] - As of the date of the announcement, the share reduction plan has not been fully implemented [1]